CLASS III Drug recall · Reported 12 Jun 2013 · FDA Enforcement Report

Target Up & Up, athlete's foot cream recalled

Novartis Consumer Health is recalling Target Up & Up, athlete's foot cream, full prescription strength, terbinafine, distributed nationwide in the US. The recall was initiated on 19 Feb 2013 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot numbers and exp dates: 10108716 31-Mar-2013, 10111510 30-Apr-2013, 10113801 31-May-2013, 10113839 30-Apr-2013, 10115616 31-Aug-2013
Quantity recalled99,660 tubes

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-574-2013
FDA event ID
64372
Recalling firm
Novartis Consumer Health, Lincoln, NE
Classification
Class III
Status
Terminated
Recall initiated
19 Feb 2013
FDA classified
6 Jun 2013
Reported
12 Jun 2013
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

19 Feb 2013Recall initiated by company
6 Jun 2013Classified by FDA+107 days
12 Jun 2013Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Labeling: Incorrect or Missing Lot and/or Expiration date; The Lot and/or Expiration date on the tube may not be legible in this lot..

Product as listed by the FDA

Target Up & Up, athlete's foot cream, full prescription strength, terbinafine hydrochloride 1% antifungal, 30 g (1 oz), compare to active ingredient in Lamisil, NDC 0067-6382-30 & UPC code: 300676382302 (Novartis) Target NDC 1167-3401-04, Distributed by Target Corp., Minneapolis, MN.

Where it was distributed

Nationwide and Puerto Rico, and Panama. Military distribution made.

Nationwide Puerto Rico

Stores named: Target

Questions about this recall

Why was it recalled?

Labeling: Incorrect or Missing Lot and/or Expiration date; The Lot and/or Expiration date on the tube may not be legible in this lot..

Which lots are affected?

Lot numbers and exp dates: 10108716 31-Mar-2013, 10111510 30-Apr-2013, 10113801 31-May-2013, 10113839 30-Apr-2013, 10115616 31-Aug-2013

Where was it sold?

Nationwide and Puerto Rico, and Panama. Military distribution made.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

4 other products · FDA event 64372

This product is part of a recall event; the main page for the event is Novartis Lamisil AT Cream, Terbinafine Hydrochloride Cream recalled.

More recalls from Novartis Consumer Health

All 60